Zenith Alpha™ Abdominal Endovascular Graft

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-24

Study Completion Date

2021-01-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

NCT02577562

Abdominal Aortic Aneurysms Aorto-iliac Aneurysms Juxtarenal Aneurysms

APPROVED_FOR_MARKETING

Zenith® AAA Endovascular Graft Clinical Study

NCT00196092

Abdominal Aortic Aneurysm

COMPLETED NA

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

NCT00875563

Abdominal Aortic Aneurysms Aorto-iliac Aneurysms Juxtarenal Aneurysms

COMPLETED NA

Zenith® Low Profile AAA Endovascular Graft

NCT02535065

Abdominal Aortic Aneurysms Iliac Aneurysms Aortoiliac Aneurysms

COMPLETED NA

Fenestrated AAA Endovascular Graft Post-Approval Study

NCT01990950

Abdominal Aortic Aneurysm (AAA) Aorto-iliac Aneurysm Juxtarenal Aneurysm

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Aortic Aorto-iliac Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zenith Alpha™ Abdominal Endovascular Graft

Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A patient is considered eligible for inclusion in the study if the patient has an infrarenal abdominal aortic or aorto-iliac aneurysm and is intended to be treated with the Zenith Alpha™ Abdominal Endovascular Graft

Exclusion Criteria

* Life expectancy less than (\<) 2 years
* Inability or refusal to give informed consent by the patient or legally authorized representative
* Unwilling or unable to comply with the study follow-up

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No